about
The apomorphine test: a biological marker for heroin dependence disorder?NATURALISTIC COURSE OF MAJOR DEPRESSIVE DISORDER PREDICTED BY CLINICAL AND STRUCTURAL NEUROIMAGING DATA: A 5-YEAR FOLLOW-UP.Validation of the Spanish version of the Borderline Symptom List, short form (BSL-23).Personality disorders do not affect treatment outcomes for chronic HCV infection in Spanish prisoners: the Perseo studyAllelic and genotypic associations of DRD2 TaqI A polymorphism with heroin dependence in Spanish subjects: a case control study.A critical analysis of user satisfaction surveys in addiction services: opioid maintenance treatment as a representative case study.Personality traits of cocaine-dependent patients associated with cocaine-positive baseline urine at hospitalization.Drug-dependent inpatients reporting continuous absence of spontaneous drug craving for the main substance throughout detoxification treatment.Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.Patient-reported outcome measures: are they patient-generated, patient-centred or patient-valued?Patient and clinician's ratings of improvement in methadone-maintained patients: Differing perspectives?Patient perception of methadone dose adequacy in methadone maintenance treatment: The role of perceived participation in dosage decisions.Personality disorders among Spanish prisoners starting hepatitis C treatment: Prevalence and associated factors.Erratum to: Validation of the Spanish version of the borderline symptom list, short form (BSL-23).Methadone tapering plus amantadine to detoxify heroin-dependent inpatients with or without an active cocaine use disorder: two randomised controlled trials.Development and psychometric properties of the Verona Service Satisfaction Scale for methadone-treated opioid-dependent patients (VSSS-MT).A controlled trial of daily versus thrice-weekly buprenorphine administration for the treatment of opioid dependence.Trends in the average prescribed dose of methadone: more than a proxy for the evolution of severity of opioid dependence.Satisfaction With Methadone and Opioid Receptor Genes Polymorphisms in Treatment-Refractory Heroin-Dependent Patients.A satisfaction survey of opioid-dependent clients at methadone treatment centres in Spain.Not all PROMs reflect patients' perspectives.Toward a genuinely patient-centered metric of depression recovery: one step further.A typology of heroin-dependent patients based on their history of self-injurious behaviours.A psychometric analysis of the Clinically Useful Depression Outcome Scale (CUDOS) in Spanish patients.Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment.Stages of change in dialectical behaviour therapy for borderline personality disorder.Satisfaction with methadone as a medication: psychometric properties of the Spanish version of the treatment satisfaction questionnaire for medication.Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment.The brain disease model of addiction: challenging or reinforcing stigma?Deep Brain Stimulation for Addiction Treatment: Further Considerations on Scientific and Ethical Issues.The Spanish version of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16): a psychometric analysis in a clinical sample.Improving systematic reviews on psychometric properties of measurement instruments: a letter to the Editor commenting on Reilly et al.'s (2015) review of the psychometric literature on QIDS.Processes of change assessment in heroin addicts following the Prochaska and DiClemente transtheoretical model.Nursing Intensive-Care Satisfaction Scale [NICSS]: Development and validation of a patient-centered instrument.Psychometric study of the Required Care Levels for People with Severe Mental Disorder Assessment Scale (ENAR-TMG).Psychometric properties of the Spanish version of the Cocaine Selective Severity Assessment to evaluate cocaine withdrawal in treatment-seeking individuals.Psychometric properties of the Spanish version of the Philadelphia Mindfulness Scale.Development and validation of the scale to assess satisfaction with medications for addiction treatment-methadone for heroin addiction (SASMAT-METHER).Cognitive predictors of illness course at 12 months after first-episode of depression.Satisfaction With Methadone Among Heroin-Dependent Patients With Current Substance Use Disorders During Methadone Maintenance Treatment.
P50
Q28212383-7748835F-86F3-4A23-B05D-5E405600F455Q31094266-165E028E-70EA-439D-B839-C765085D1E10Q34722089-3D655F99-ACBC-4509-A3F6-899ABD17C4AFQ35749560-BDCBC266-92FF-4224-BBE7-31E266E75BCFQ35842377-F14AEBC6-CC6C-48D5-8668-DCB0EECFA138Q37525916-FFB9F4B2-0C2A-4F05-9433-D2D76431CEF7Q37689169-DFDB8E09-DD47-4002-A143-5B161EAD35EFQ37847629-A0402E21-424C-4265-9E8E-09DAEA63D015Q38065287-3A3E34C7-8ED3-452A-B4FD-4C5378133138Q38074478-6FBE4FC5-8DF2-49AA-9899-D74E4EBF94B9Q38495431-651E62DB-48B3-4884-BB92-028ECA146E5CQ39092503-7D15FBA8-C6DB-431A-B217-B899D701DBF0Q40280427-E645CD15-2BFF-48DD-BC14-554F2D2F0652Q42359786-8AE1CDB0-1238-4B55-B4D8-D882D3C992C4Q43620007-EF0B6EFA-75A2-4FA9-B8D2-ECB38D41B073Q44138252-AA262D08-195B-4816-B4B9-AB997245F321Q44331658-F82583C6-727D-4083-B46E-15C287048DD9Q44339303-315206AF-9296-4534-B132-4951F5F267ECQ44344272-74E43508-FDC8-4790-9421-CF15EC0FDB67Q44344897-F12CB610-9038-4A18-B726-0F0830DFBC8FQ44510239-D123911A-E92F-40A0-A0E4-9335D0D93C44Q44641182-E1389BF6-B80C-4DF0-AFF8-458B090A8AFDQ45113782-8819913C-A41A-4CFA-8D88-7AB2098B0FF2Q46371611-1FBADB68-3A4F-40D9-B355-33C79FA45F3AQ46470950-5E23B3C5-1B77-4C4D-AC23-DECE3F34B272Q46584793-AE01BE49-AF96-4730-AEAB-929B95090160Q47239626-512A6385-B587-4D78-9CE8-D36D1D6ADA3DQ47563773-55ED30AC-17F5-47D4-865F-9BC43E1FDB41Q47615777-71CA237A-A73D-40B9-B320-58213B0D49E9Q48007652-7FD337C9-E7E9-42AD-9561-D5AF3EED5C14Q48065679-5FFF67C9-C917-4AFB-A417-F06782A13F2DQ48115384-FEFAA986-B800-41B3-B69E-CC923E0B3ED9Q48742444-A973734A-8F00-4A9A-BF6C-41926E5FE82EQ49997562-544932BC-13B9-4963-AFAB-903259D43042Q50249209-16DC5AD6-4336-4D02-9EA5-364119BEBA55Q50466211-5460728D-5F1A-4777-B5FF-D5B7348233A1Q50466830-634C60B7-0DE9-4403-A344-BCCDE451244FQ50467499-624C1140-57DA-4E40-9425-205943773B22Q50534238-B5FCA8B8-61B7-4577-90F5-1F249B88EFF8Q50543789-D057B73A-16D4-4266-9FBB-6135477527CB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joan Trujols
@ast
Joan Trujols
@en
Joan Trujols
@es
Joan Trujols
@nl
Joan Trujols
@sl
type
label
Joan Trujols
@ast
Joan Trujols
@en
Joan Trujols
@es
Joan Trujols
@nl
Joan Trujols
@sl
altLabel
Joan Trujols-Albet
@en
prefLabel
Joan Trujols
@ast
Joan Trujols
@en
Joan Trujols
@es
Joan Trujols
@nl
Joan Trujols
@sl
P106
P1153
6602827722
P31
P496
0000-0003-0396-7105